Rose became acquainted with Patient Worthy after her husband was diagnosed with Acute Myeloid Leukemia (AML) six years ago. During this period of partial remission, Rose researched investigational drugs to be prepared in the event of a relapse. Her husband died February 12, 2021 with a rare and unexplained occurrence of liver cancer possibly unrelated to AML.
https://unsplash.com/photos/tV-RX0beDp8
Patients who have been heavily pretreated for relapsed/refractory multiple myeloma participated in the phase 2 study of bispecific T cell redirection antibodies. The participants responded to treatment with a combination…
Continue Reading
Bispecific T-Cell Redirection Antibodies in the Treatment of Multiple Myeloma
Pixabay
June 17th is International CDKL5 Day. During the month of June let’s tag every day with a reminder to those in the CDKL5 community to promote collaboration and fundraising.…
Continue Reading
June 17th is International CDKL5 Day
source: pixabay.com
Effective June 1, 2023, the FDA lifted its clinical hold on Foghorn Therapeutics’ Phase 1 study of FHD-286 dose escalation in patients with acute myeloid leukemia and myelodysplastic syndromes. The…
Continue Reading
FDA Lifts Clinical Hold on Phase 1 AML and MDS Clinical Trial
source: pixabay.com
An observational study of 599 survivors of COVID-19 was conducted at the Papa Giovanni Hospital in Bergamo, Italy three months after hospital admission. The patients were evaluated for thyroglobulin…
Continue Reading
Could COVID-19 be a Cause of Autoimmune Thyroid Disease?
source: pixabay.com
Relyvrio was officially approved by the FDA for treating ALS in September 2022. However, according to an article in BioPharma Dive, there was considerable controversy surrounding the clearance of the…
Continue Reading
ALS Drug Facing Possible Rejection by the European Medicines Agency
An announcement by Pfizer was recently published in Biospace outlining the results of BASIS its Phase 3 clinical trial (NCT03938792). The drug being studied, marstacimab, met its primary endpoints…
Continue Reading
Experimental Therapy for Hemophilia Meets Phase 3 Trial Endpoints
Céline Dion’s new milestone is her first-ever film, Love Again, which she stars in while living with a rare disease called stiff person syndrome. Céline expressed her wishes that…
Continue Reading
Celine Dion Isn’t Slowing Down Despite Stiff Person Syndrome Diagnosis
source: shutterstock.com
A court in Zabbar, Malta found the parents of seven-year-old Victoria guilty of her death by negligence. The court also determined that the system had failed the child by…
Continue Reading
Parents in Malta Handed a Prison Sentence for the Death of Daughter Who Died of Aplastic Anemia
source: shutterstock.com
In Japan researchers at the Juntendo University have discovered that when ECHS1 enzyme variations of mitochondrial enoyl-CoA hydratase short chain 1 (ECHS 1) do not function properly, they cause…
Continue Reading
A High-Efficiency Assay with Rapid Mitochondrial Disease Diagnosis
source: shutterstock.com
WebMD recently carried a story about a young woman who, after nine years of wheelchair confinement caused by a rare metabolic disease with no name, was able to walk…
Continue Reading
Drug Repurposing: Saving Rare Disease Patient Lives
The FDA has approved the drug Ayvakit developed by the biotechnology company Blueprint Medicines for the treatment of indolent systemic mastocytosis. According to an article in BiopharmaDive, Ayvakit had been…
Continue Reading
The FDA Has Approved Ayvakit for the Treatment of Indolent Systemic Mastocytosis
source: shutterstock.com
As clinicians and scientists continue to delve into RNA sequencing benefits, they are learning how RNA sequencing provides insights for people with rare genetic conditions. The learning experience will provide…
Continue Reading
RNA Sequencing: Hope for Improved Rare Disease Diagnosis
source: pixabay.com
Fierce Biotech recently carried an article about the death of Terry Horgan. Terry was a 27-year-old Duchenne muscular dystrophy (DMD) patient and the brother of the CEO of the…
Continue Reading
Duchenne Muscular Dystrophy Patient Dies in Gene Therapy Trial
source: pixabay.com
John knew from an early age that he not only loved music but had confidence in his musical ability. However, there was another very troubling issue in his life. John…
Continue Reading
This Spinal Muscular Atrophy Patient Established a Nonprofit for Disabled Artists
source: pixabay.com
The biotechnology company Anixa Biosciences, Inc. together with the Moffitt Cancer Center, issued a press release on May 22nd stating that the second patient had begun treatment as part…
Continue Reading
Ovarian Cancer: Second Patient Treated with Novel CAR-T in Trial
source: pixabay.com
Thirty-year-old Brendan O’Reilly was told that his rare disease affects only one person in 250,000. He was also told that he is lucky to be alive. Brendan’s symptoms confused…
Continue Reading
Acute Disseminated Encephalomyelitis Can be Confused for a Stroke
The Chow family was told that their 33-year-old daughter, Brittney, would have to wait about twelve years for a kidney transplant. There were currently no kidneys available for transplantation. Elizabeth…
Continue Reading
There Is No Limit to What Some Mothers Will Do For Their Children.
In March the FDA’s expert advisers voted 11 to 2 in favor of approving Roche’s antibody drug Polivy to treat lymphoma patients. According to an article in BiopharmaDive, the decision…
Continue Reading
The FDA Approves Roche’s Antibody Drug Polivy to Treat Lymphoma Patients
The safety, pharmacokinetics (absorption), and tolerability of the investigational eIF2B activator ABBV-CLS-7262 is being evaluated in a Phase 1b clinical study to treat patients with Vanishing White Matter (VWM) Disease.…
Continue Reading
ABBV CLS 7262 is Being Evaluated as a Potential Treatment for Vanishing White Matter Disease in the Brain
PhRMA Public Affairs recently carried the good news that Governor Holcomb of Indiana has joined the governors of Arkansas and West Virginia by signing a law aptly named 'Share the…
Continue Reading
Indiana Legislature Passes Bill Protecting Patients from Paying More Than Their Insurers
This week PR Newswire carried an announcement by the biotechnology company Immunic Inc. of preclinical data confirming that Vidofludimus Calcium (IMU 838) may be a Nurr 1-Activator reinforcement. Immunic is…
Continue Reading
Immunic Inc. Announces Promising Pre-Clinical Findings for Multiple Sclerosis
source: pixabay.com
For patients who were given a diagnosis of advanced, inoperable (unresectable) biliary tract cancer, an article appeared in Healio with some encouraging news. Gemcitabine and cisplatin drugs have…
Continue Reading
A Glimmer of Hope for Patients with Advanced Biliary Tract Cancer
source: pixabay.com
Omisirge (omidubicel) is the first allogeneic (from a donor) product for SCT that has been the recipient of FDA approval. The FDA's nod moves Omisirge into the realm of…
Continue Reading
New Cell Therapy Approved by the FDA to Reduce Risk of Infection After Transplant
source: shutterstock.com
The damage caused by cocaine can sometimes be misdiagnosed as a rare disease: granulomatosis with polyangiitis. Cocaine use has been increasing in America and the UK, resulting in serious…
Continue Reading
Damage from Cocaine Abuse can be Misdiagnosed as Granulomatosis with Polyangiitis
source: shutterstock.com
Compassion [kuhm-pash-uhn] noun A feeling of deep sympathy and sorrow for another who is stricken by misfortune, accompanied by a strong desire to alleviate the suffering. Compassion Corner is a…
Continue Reading
Compassion Corner: Compassion Should be Reciprocal: The Rising Suicide Rate of Physicians and Nurses